secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2026-05-14T20:06:06+00:00
Accession:  0001193125-26-223985
Event type: earnings
Sentiment:  negative
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Q1 net loss $4.4M ($2.11/share); Zola volumes +18% YoY
--------------------------------------------------------------

- Net loss attributable to common stockholders $4.385M (EPS -$2.11) vs net income $2.599M ($1.90 EPS) in Q1 2025.
- Zola coconut water unit volume +18% YoY; total revenue $1.1M down 8% due to $193k revenue reserve release in prior year.
- SG&A $1.179M, lowest in public company history, down $559k YoY; cash and equivalents $0.954M vs $0.259M at year-end.
- January 2026 warrant inducement generated $2.1M gross proceeds but caused $2.877M loss; company continues evaluating strategic alternatives.
- Company plans new product launch fall 2026; Zola benefited from price increase at start of year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000119312526223985/0001193125-26-223985-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000119312526223985/rkda-20260514.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-223985

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer